Recent progress in bioresorbable stents(BRSs)has provided a promising alternative for treating coronary artery disease.However,there is still lack of BRSs with satisfied compression and degradation performance for ped...Recent progress in bioresorbable stents(BRSs)has provided a promising alternative for treating coronary artery disease.However,there is still lack of BRSs with satisfied compression and degradation performance for pediatric patients with congenital heart disease,leading to suboptimal therapy effects.Here,we developed a mechanically self-reinforced composite bioresorbable stent(cBRS)for congenital heart disease application.The cBRS consisted of poly(p-dioxanone)monofilaments and polycaprolactone/poly(p-dioxanone)core-shell composite yarns.Interlacing points in cBRS structure were partially bonded,offering the cBRS with significantly higher compression force compared to typical braids and remained good compliance.The suitable degradation profile of the cBRS can possibly preserve vascular remodeling and healing process.In addition,the controllable structural organization provides a method to customize the performance of the cBRS by altering the proportion of different components in the braids.The in vivo results suggested the cBRS supported the vessel wall similar to that of metallic stent.In both abdominal aorta and iliac artery of porcine,cBRS was entirely endothelialized within 1 month and maintained target vessels with good patency in the 12-month follow-up.The in vivo degradation profile of the cBRS is consistent with static degradation results in vitro.It is also demonstrated that there is minimal impact of pulsatile pressure of blood flow and variation of radial force on the degradation rate of the cBRS.Moreover,the lumen of cBRS implanted vessels were enlarged after 6 months,and significantly larger than the vessels implanted with metallic stent in 12 months.展开更多
基金The project is supported by the Fundamental Research Funds for the Central Universities(grant No.2232017A-05,2232019A3-06)Science and Technology Support Program of Shanghai(grant No.16441903803,18441902600)the Chinese Universities Scientific Fund(grant No.CUSF-DH-D-2017012)and 111 project(grant No.B07024).
文摘Recent progress in bioresorbable stents(BRSs)has provided a promising alternative for treating coronary artery disease.However,there is still lack of BRSs with satisfied compression and degradation performance for pediatric patients with congenital heart disease,leading to suboptimal therapy effects.Here,we developed a mechanically self-reinforced composite bioresorbable stent(cBRS)for congenital heart disease application.The cBRS consisted of poly(p-dioxanone)monofilaments and polycaprolactone/poly(p-dioxanone)core-shell composite yarns.Interlacing points in cBRS structure were partially bonded,offering the cBRS with significantly higher compression force compared to typical braids and remained good compliance.The suitable degradation profile of the cBRS can possibly preserve vascular remodeling and healing process.In addition,the controllable structural organization provides a method to customize the performance of the cBRS by altering the proportion of different components in the braids.The in vivo results suggested the cBRS supported the vessel wall similar to that of metallic stent.In both abdominal aorta and iliac artery of porcine,cBRS was entirely endothelialized within 1 month and maintained target vessels with good patency in the 12-month follow-up.The in vivo degradation profile of the cBRS is consistent with static degradation results in vitro.It is also demonstrated that there is minimal impact of pulsatile pressure of blood flow and variation of radial force on the degradation rate of the cBRS.Moreover,the lumen of cBRS implanted vessels were enlarged after 6 months,and significantly larger than the vessels implanted with metallic stent in 12 months.
